Replication or exploration? Sequential design for stochastic simulation experiments M Binois, J Huang, RB Gramacy, M Ludkovski Technometrics 61 (1), 7-23, 2019 | 127 | 2019 |
Analyzing stochastic computer models: A review with opportunities E Baker, P Barbillon, A Fadikar, RB Gramacy, R Herbei, D Higdon, ... Statistical Science 37 (1), 64-89, 2022 | 50* | 2022 |
On‐site surrogates for large‐scale calibration J Huang, RB Gramacy, M Binois, M Libraschi Applied Stochastic Models in Business and Industry 36 (2), 283-304, 2020 | 14 | 2020 |
Mosunetuzumab monotherapy continues to demonstrate durable responses in patients with relapsed and/or refractory follicular lymphoma after≥ 2 prior therapies: 3-year follow-up … SJ Schuster, LH Sehn, NL Bartlett, M Matasar, S Assouline, P Giri, ... Blood 142, 603, 2023 | 13 | 2023 |
Mosunetuzumab Monotherapy Demonstrates Activity and a Manageable Safety Profile in Patients with Relapsed or Refractory Richter's Transformation CY Cheah, S Assouline, R Baker, NL Bartlett, D El-Sharkawi, P Giri, M Ku, ... Blood 142, 614, 2023 | 4 | 2023 |
Multi-output calibration of a honeycomb seal via on-site surrogates J Huang, RB Gramacy Technometrics 64 (4), 548-563, 2022 | 4 | 2022 |
CAMMA 1: a multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of cevostamab-containing regimens in patients with relapsed or refractory multiple … R Vij, H Schade, S Trudel, AC Chang, J Huang, D Samineni, T Sumiyoshi, ... J. Clin. Oncol 40, 16, 2022 | 3 | 2022 |
A frequentist approach to dynamic borrowing R Li, R Lin, J Huang, L Tian, J Zhu Biometrical Journal 65 (7), 2100406, 2023 | 2 | 2023 |
CAMMA 3: A multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of subcutaneous cevostamab monotherapy in patients with relapsed or refractory … S Delimpasi, H Quach, M Cavo, PJ Ho, C Lee, A Santoro, R Schots, ... J. Clin. Oncol 40, 16, 2022 | 1 | 2022 |
Sequential learning, large-scale calibration, and uncertainty quantification J Huang Virginia Tech, 2019 | 1 | 2019 |
PB2034: CAMMA 1: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS AND ACTIVITY OF CEVOSTAMAB-CONTAINING REGIMENS IN PATIENTS WITH RELAPSED OR REFRACTORY … R Vij, H Schade, S Trudel, AC Chang, J Huang, D Samineni, T Sumiyoshi, ... HemaSphere 6, 1905-1906, 2022 | | 2022 |
Bayesian Analysis of Rank Data with Covariates and Heterogeneous Rankers...................................................... Xinran Li, Dingdong Yi and Jun S. Liu 1 The … M Oesting, K Strokorb, P Barbillon, A Fadikar, RB Gramacy, R Herbei, ... Statistical Science [ISSN 0883-4237 (print); ISSN 2168-8745 (online)] 37 (1), 2022 | | 2022 |
DECONSTRUCTIVE ANALYSIS OF DIGITAL PATHOLOGY INFERENCES US Patent App. No. 63/394,934, 0 | | |